Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
The latest in news from I-MAK experts.
For press inquiries, please contact simon@i-mak.org.
Medicines access group takes aim at Sovaldi patents
As more countries around the world reject unmerited patents for Sovaldi®, I-MAK Files Two New U.S. Patent Challenges on Gilead’s Hepatitis C Portfolio
Argentina Rejects Key Patent on Hepatitis C Drug
Patent ‘Trolls’ Recede as Threat to Innovation. Will Justices Change That?
Patent Fighters: Taking on Big Pharma
There Is Only One Sure Way to Fix the Hepatitis C Epidemic
Seven Days
Nonprofit challenges Gilead’s patents on sofosbuvir
Nonprofit Group I-MAK Files IPR Petitions Seeking to Invalidate Hepatitis C Drug Patent
Trending News Today: Gilead HCV Drug Patents Challenged